The aim of the present work was to develop and validate an HPLC-MS/MS method for the determination of a major pyrrolizidine alkaloid of comfrey (lycopsamine) in aqueous samples as a basis for the development of a method for the determination of absorption of lycopsamine by human skin. A linear calibration curve was established in the range of 1.32-440 ng. The intraday precision during the 3-day validation period ranged between 0.57 and 2.48% while the interday precision was 1.70% and 1.95% for quality control samples. LOD was 0.014 ng and recovery was above 97%. The lycopsamine content of the samples stored for 9 and 25 days at 22°C, 10°C and -25°C did not vary. These results underline the good repeatability and accuracy of our method and allow the analysis of samples with very low lycopsamine content.
Although some pyrrolizidine alkaloids (PA) are hepatotoxins, certain plants containing these secondary metabolites are used in modern phytotherapy. The industrially most important species is Symphytum officinale (common comfrey), which contains 0.2-0.4% pyrrolizidine alkaloids. Comfrey root has been applied externally for inflammatory disorders of joints, wounds, gout, bone fractures, distorsions, haematomas and thrombophlebitis [1] . Many pyrrolizidine alkaloids are known to produce pronounced hepatic toxicity and there are many recorded cases of livestock poisoning. It has to be noted that these alkaloids are non-toxic, but when they are transformed by mammalian liver oxidases into reactive pyrrole structures, they become potent alkylating agents and react with suitable cell nucleophiles, e.g. nucleic acids and proteins [2] .
In certain European countries, the PA content of medicinal products is restricted, but there is no EU regulation for the upper limit. In Germany the maximal daily dose of PAs in the case of cutaneous application is 100 µg for a maximum of 6 weeks/year and 10 µg without any limitation in the duration of use [3] . In the UK, the Medicine Control Agency included comfrey in a list of herbs under consideration for restriction to physician prescription only. In the USA, the Food and Drug Administration has requested voluntary compliance for removal of products containing comfrey [4] . However, no relevant human data are available on the absorption of PAs after external application. One limitation of such studies is the lack of appropriate validated analytical methods. Our experiments aimed at the development of a reliable LC-MS method for the quantitative determination of an alkaloid of common comfrey, lycopsamine, in order to provide a basis for possible pharmacokinetic studies. The method described below is suitable for the rapid and reliable determination of lycopsamine.
The effect of acetic acid concentration on the measured peak area: As eluent acidity highly affects the efficiency of the method, we examined the effect of acetic acid concentration of the samples on the measured peak area. It has been found that the acid concentration did not influence the peak area. The relative standard deviation of three replicate measurements was about 15% without acid and about 3% with acid, but it was independent of the acid concentration. Therefore, during validation, all solutions and samples were prepared with acetonitrile and water with 0.1% acetic acid (50:50).
Calibration curve and linearity:
A linearity curve for lycopsamine was obtained in a mass range of 1.32-3960 ng. A linear calibration curve was established in the range 1.32-440 ng (Figure 1 Jedlinszki & Csupor parameters of the calibration curves during the 3-day validation can be seen in Tables 1 and 2 .
Precision:
The intraday and interday precision in the 3-day validation process for lycopsamine are summarized in Table 3 . Intraday precision ranged between 0.57 and 2.48% while the interday precision was 1.70% for the LC sample and 1.95% for the HC sample. These results underline the good repeatability of our method.
Limit of detection (LOD) and limit of quantitation (LOQ):
A series of dilutions from the stock solution was made and measured. LOD was 0.014 ng (S/N=10) and LOQ (5*LOD) was 0.070 ng (S/N=31). These results allow the analysis of samples with very low lycopsamine content.
Recovery:
The recovery of lycopsamine was between 97.7% and 104.3%. These results confirm the good accuracy of our method.
Stability:
The lycopsamine content of the samples stored for 9 and 25 days at room temperature, in a refrigerator and at -25°C did not alter.
These results indicate that lycopsamine is stable in aqueous solution and therefore analysis can be carried out reliably of samples stored for short periods.
Conclusion:
Due to the relatively low amount of PAs in medicinal products and especially in biological samples used for pharmacokinetic studies, highly sensitive analytical methods are needed for quantification. To date mass spectrometry (MS) coupled with either liquid or gas chromatography is the most widely applied method for such analyses. The majority of the articles focus on honey analysis. Kempf et al. compared GC-MS and LC-MS methods for the determination of PAs in honey, without analytical validation of these methods [5] . Typical LOQs of LC-MS analyses of honey samples are in the μg/kg range [6] . Recently, an ELISAbased screening assay has been reported for the detection of pyrrolizidine alkaloids in honey. The LOD of this method is 25 μg/kg [7] . 
HPLC-MS apparatus and measurement conditions:
Chromatographic separation was performed using a Shimadzu liquid chromatographic system equipped with a Phenomenex Gemini C18 (100 x 4.6 mm, 5 µm) column. Isocratic elution was applied using acetonitrile and water with 0.1% acetic acid (50:50). The flow rate was 0.4 mL/min. The HPLC was coupled to an API 2000 MS/MS with an electrospray ionization (ESI) interface. The source temperature was 350°C. The measurements were carried out in positive ionization mode and the quantification was accomplished using multiple reaction monitoring (MRM) with transitions of m/z 300→156 for lycopsamine. Parameter optimization, data acquisition and evaluation were performed using Analyst 1.5.2 software.
